Navigation Links
New Blood Thinner Beats Plavix When Paired With Low-Dose Aspirin
Date:6/27/2011

MONDAY, June 27 (HealthDay News) -- Brilinta, an experimental anti-clotting medication currently awaiting U.S. Food and Drug Administration approval, performed better than the industry standard, Plavix, when used in tandem with low-dose aspirin, a new study finds.

Heart patients who took Brilinta (ticagrelor) with low-dose aspirin (less than 300 milligrams) had fewer cardiovascular complications than those taking Plavix (clopidogrel) plus low-dose aspirin, researchers found.

However, patients who took Brilinta with higher doses of aspirin (more than 300 milligrams) had worse outcomes than those who took Plavix plus high-dose aspirin, the investigators reported.

Antiplatelet drugs are used to prevent potentially dangerous blood clots from forming in patients with acute coronary syndrome, including those who have had a heart attack.

Brilinta has already been approved for use in many other countries. In July 2010, an FDA panel voted 7-to-1 to approve the use of Brilinta for U.S. patients undergoing angioplasty or stenting to open blocked arteries, but the approval process is still ongoing.

The panel's recommendation was based in part on prior findings from this study, called the Platelet Inhibition and Patient Outcomes (PLATO) trial.

In this latest analysis of PLATO findings, researchers found that patients who took Brilinta with low-dose aspirin were 16 percent less likely than those who took Plavix with low-dose aspirin to have a heart attack or stroke, or to die within a year.

The findings were reported Monday in an American Heart Association online conference.

One expert said the new information is valuable.

"The study highlights that if one chooses to use ticagrelor in subjects with acute coronary syndromes, it would be logical to use aspirin 81 milligrams per day (and not 325 mg daily)," said Dr. Jeffrey S. Berger, assistant professor of medicine and director of cardiovascular thrombosis at NYU Langone Medical Center in New York City. "Of note, there is little reason to ever use aspirin 325 mg except in the acute setting of a heart attack or stroke," he added. "A higher aspirin dose (325 mg versus 81 mg) increases the risk of bleeding without increasing the efficacy of the drug."

A study author agreed that for most patients, using the drug with a lower dose of aspirin is usually warranted.

"Patients with acute coronary syndrome have options to prevent recurrent events," study lead author Dr. Kenneth W. Mahaffey, co-director of cardiovascular research at the Duke Clinical Research Institute, and associate professor of medicine at Duke University Medical Center, said in an AHA news release. "Physicians choosing to use ticagrelor in countries where it is approved and available should consider using a low-dose of maintenance aspirin with the drug."

The data and conclusions of the research should be viewed as preliminary until published in a peer-reviewed journal.

More information

The American Academy of Family Physicians outlines medicines used to treat patients with acute coronary syndrome.

-- Robert Preidt

SOURCES: Jeffrey S. Berger, M.D., assistant professor, medicine and director, cardiovascular thrombosis, NYU Langone Medical Center, New York City; American Heart Association, news release, June 27, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. In a new post-hoc analysis, significantly more patients achieved blood sugar goals with JANUMET
2. To fix diabetic nerve damage, blood vessels and support cells may be the real targets of treatment
3. Hereditary colon cancer syndrome marked by abnormally dense blood vessel growth in mouth
4. Less Invasive Colon Surgery Results in Fewer Blood Clots: Study
5. Single Reading Cant Gauge Blood Pressure Control: Study
6. Nanoparticles disguised as red blood cells will deliver cancer-fighting drugs
7. Medical Groups Update Heart, Blood Pressure Care Guidelines
8. New strategy to attack tumor-feeding blood vessels
9. Popular Blood Pressure Meds Not Linked to Cancer, FDA Says
10. In the lab and clinic, VCU Massey develops a new therapy for blood cancers
11. NIH-funded researchers find new ways to confuse blood-seeking mosquitoes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Blood Thinner Beats Plavix When Paired With Low-Dose Aspirin
(Date:5/26/2016)... ... May 26, 2016 , ... May 2016 – Lips ... central to popular cosmetic improvement efforts. Record numbers of clients now ask about lip ... or pouty, says Kally Papantoniou, MD, of Advanced Dermatology P.C. , The ...
(Date:5/26/2016)... (PRWEB) , ... May 26, ... ... organization promoting quality-based imaging practices, is seeking nominations to serve on its ... diagnostic imaging. , “RadSite’s quality-benchmarking activities incorporate key process and ...
(Date:5/26/2016)... ... May 26, 2016 , ... In Madeira Beach Florida, a ... a single drawbridge, citizens formed an organization, Madeira Beach United, to oppose two development ... the small town center to a high rise urban environment. , According to the ...
(Date:5/26/2016)... ... 26, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star ... High blood pressure affects millions of people worldwide, and many patients use prescription ... heart disease, stroke, kidney disease, and hardening of the arteries. However, prescription medications ...
(Date:5/26/2016)... ... May 26, 2016 , ... With long-term experience ... President of Business Intelligence and Informatics, effective immediately. http://www.fluidedgeconsulting.com , As ... as a healthcare business and financial strategist for over 20 years. By ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25, 2016  Zymo Research ... for their new reference materials that help researchers ... sample collection to analyses. The rapid growth of ... for researchers to have standard methods to improve ... generated. Biases inherently exist at every step of ...
(Date:5/25/2016)... As illustrated by the Spring ... the numbers and momentum of cannabis in the US ... billions, more research and development push the sector forward. ... Legal Marijuana Markets Report  from from ArcView Market Research ... the increase in sector is attributed to adult use ...
(Date:5/25/2016)... , May 25, 2016 MedDay, a ... announces that an oral presentation entitled "High doses of biotin ... trial" will be given by Professor Ayman Tourbah , ... Congress of the European Academy of Neurology (EAN) in ... related disorders 3" will take place on Sunday, 29 May ...
Breaking Medicine Technology: